"
Team:Hong Kong HKUST/hp/interview/yu
From 2013.igem.org
(Difference between revisions)
CeciliaShi (Talk | contribs) |
|||
| (7 intermediate revisions not shown) | |||
| Line 69: | Line 69: | ||
{visibility:hidden;} | {visibility:hidden;} | ||
#globalWrapper | #globalWrapper | ||
| - | {position: relative;font-size:127%;width:100%;margin:0;padding:0;padding-bottom:10px;background-color:#494042;height: | + | {position: relative;font-size:127%;width:100%;margin:0;padding:0;padding-bottom:10px;background-color:#494042;height:1350px;} |
#content | #content | ||
| - | {width: 995px;border:none;background-color:#ffffff;height: | + | {width: 995px;border:none;background-color:#ffffff;height:1300px;padding:0px;margin-top:0px;line-height: 1.5em;color: black;} |
#top-section | #top-section | ||
{height:2px;border:none;background-color:#494042;} | {height:2px;border:none;background-color:#494042;} | ||
| Line 173: | Line 173: | ||
top: 10%; | top: 10%; | ||
right: 2%; | right: 2%; | ||
| + | z-index:16; | ||
} | } | ||
#back-top a { | #back-top a { | ||
| Line 299: | Line 300: | ||
#msk3{margin-left:35px;} | #msk3{margin-left:35px;} | ||
#msk4{margin-left:70px;} | #msk4{margin-left:70px;} | ||
| + | |||
| + | #iGEM_Logo{ | ||
| + | width:100px; | ||
| + | height:80px; | ||
| + | position:absolute; | ||
| + | right:10px; | ||
| + | top:60px; | ||
| + | z-index:+15; | ||
| + | } | ||
| + | #hkust_Logo{ | ||
| + | width:60px; | ||
| + | height:80px; | ||
| + | position:absolute; | ||
| + | right:110px; | ||
| + | top:60px; | ||
| + | z-index:+15; | ||
| + | } | ||
| + | |||
| + | |||
</style> | </style> | ||
<body> | <body> | ||
| + | |||
| + | |||
| + | <a href="https://2013.igem.org/Main_Page"><img id="iGEM_Logo" src="https://static.igem.org/mediawiki/2013/4/46/Igem_qgem_logo.png"></a> | ||
| + | |||
| + | |||
| + | <a href="http://www.ust.hk/eng/index.htm"><img id="hkust_Logo" src="https://static.igem.org/mediawiki/2013/5/55/Hkust_logo.gif"></a> | ||
| + | |||
| + | |||
<p id="back-top" style="display:none;"> | <p id="back-top" style="display:none;"> | ||
<a href="#top"><span><img src="http://515alive.com/theme/img/up-arrow.png" style="width:90%;"><br><br>BACK TO TOP</span></a> | <a href="#top"><span><img src="http://515alive.com/theme/img/up-arrow.png" style="width:90%;"><br><br>BACK TO TOP</span></a> | ||
| Line 366: | Line 394: | ||
<div class="row"> | <div class="row"> | ||
<div class="two columns"><br> | <div class="two columns"><br> | ||
| - | <ul class="side-nav"> | + | <ul class="side-nav"> |
<li> | <li> | ||
| - | <h6> | + | <h6>Interview</h6> |
</li> | </li> | ||
<li class="divider"></li> | <li class="divider"></li> | ||
<li> | <li> | ||
| + | Prof. Albert Yu<ul><li> | ||
<a href=#1>Introduction</a> | <a href=#1>Introduction</a> | ||
</li> | </li> | ||
| Line 379: | Line 408: | ||
<li> | <li> | ||
<a href=#3>Conclusion</a> | <a href=#3>Conclusion</a> | ||
| - | |||
| - | |||
| - | |||
</li> | </li> | ||
<li> | <li> | ||
| Line 388: | Line 414: | ||
<a href=#6>Download Links</a> | <a href=#6>Download Links</a> | ||
</li> | </li> | ||
| - | + | </ul> | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
</li> | </li> | ||
<li> | <li> | ||
| Line 417: | Line 432: | ||
<div class="nine columns"><p id="1"></p> | <div class="nine columns"><p id="1"></p> | ||
<h3>Overview</h3> | <h3>Overview</h3> | ||
| - | Professor Albert Yu is the chairman of the Hong Kong Biotechnology Organization (HKBIO), and also a professor of the Department of Neurobiology of Peking University, China. As an entrepreneur and a scientist, Prof. Yu gave us realistic insights to our project. Meeting Prof. Yu helped us to evaluate our project beyond the laboratory environment and to think about | + | Professor Albert Yu is the chairman of the Hong Kong Biotechnology Organization (HKBIO), and also a professor of the Department of Neurobiology of Peking University, China. As an entrepreneur and a scientist, Prof. Yu gave us realistic insights to our project. Meeting Prof. Yu helped us to evaluate our project beyond the laboratory environment and to think about its possible future application as a biotechnology product. Towards the end of the interview, we also talked about the bioethics and biosafety issues regarding synthetic biology. |
<br> | <br> | ||
</div> | </div> | ||
| Line 427: | Line 442: | ||
<h3>Main Discussion</h3> | <h3>Main Discussion</h3> | ||
Prof. Yu mentioned that our project is a small step and that we have a long way to go to apply our project as a commercial biotechnology product. He told us that because we are trying to insert genes into a human body, we need to be very careful with concluding how our project could be realistically applied in the future. Inserting genes into a human body can create novel metabolism properties that could lead to side effects. Also, because the general public considers obesity less harmful, people might be reluctant to sign up for invasive treatment if they believe a less invasive means such as exercising can solve the problem. He also encouraged us to look into other plant genes that could be used to cure fatal diseases.<br><br> | Prof. Yu mentioned that our project is a small step and that we have a long way to go to apply our project as a commercial biotechnology product. He told us that because we are trying to insert genes into a human body, we need to be very careful with concluding how our project could be realistically applied in the future. Inserting genes into a human body can create novel metabolism properties that could lead to side effects. Also, because the general public considers obesity less harmful, people might be reluctant to sign up for invasive treatment if they believe a less invasive means such as exercising can solve the problem. He also encouraged us to look into other plant genes that could be used to cure fatal diseases.<br><br> | ||
| - | We also discussed about issues on | + | We also discussed about issues on biosafety and bioethics. Prof. Yu said that we need to be responsible scientists and utilize research to improve human life. He also mentioned that to produce a bioproduct, it is very important to consider the ethical issues of the project from the very start. |
<br> | <br> | ||
| Line 441: | Line 456: | ||
</div> | </div> | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
<div class="row"> | <div class="row"> | ||
<div class="nine columns"><p id="5"></p> | <div class="nine columns"><p id="5"></p> | ||
| Line 457: | Line 468: | ||
<h3>Download Links</h3> | <h3>Download Links</h3> | ||
| - | <i>Right-click and click "Save link as.." on the link | + | <i>Right-click and click "Save link as..." on the link to items that you want to download.</i> |
<br><br> | <br><br> | ||
<a href="https://static.igem.org/mediawiki/2013/c/c8/Interview_Appendix_-_Prof._Yu.pdf">Prof. Yu's Interview Script (PDF)</a> | <a href="https://static.igem.org/mediawiki/2013/c/c8/Interview_Appendix_-_Prof._Yu.pdf">Prof. Yu's Interview Script (PDF)</a> | ||
Latest revision as of 12:56, 28 October 2013
-
Interview
- Prof. Albert Yu
- Prof. Juliana Chan
Prof. Albert Yu
Overview
Professor Albert Yu is the chairman of the Hong Kong Biotechnology Organization (HKBIO), and also a professor of the Department of Neurobiology of Peking University, China. As an entrepreneur and a scientist, Prof. Yu gave us realistic insights to our project. Meeting Prof. Yu helped us to evaluate our project beyond the laboratory environment and to think about its possible future application as a biotechnology product. Towards the end of the interview, we also talked about the bioethics and biosafety issues regarding synthetic biology.Main Discussion
Prof. Yu mentioned that our project is a small step and that we have a long way to go to apply our project as a commercial biotechnology product. He told us that because we are trying to insert genes into a human body, we need to be very careful with concluding how our project could be realistically applied in the future. Inserting genes into a human body can create novel metabolism properties that could lead to side effects. Also, because the general public considers obesity less harmful, people might be reluctant to sign up for invasive treatment if they believe a less invasive means such as exercising can solve the problem. He also encouraged us to look into other plant genes that could be used to cure fatal diseases.We also discussed about issues on biosafety and bioethics. Prof. Yu said that we need to be responsible scientists and utilize research to improve human life. He also mentioned that to produce a bioproduct, it is very important to consider the ethical issues of the project from the very start.
Conclusion
The interview with Professor Albert Yu helped us to realize the social environment our project would encounter, and the barriers that come with it. The interview also showed that more in-depth consideration of our project’s future application is necessary if we want to see it utilized as a safe bioproduct.Pictures
Download Links
Right-click and click "Save link as..." on the link to items that you want to download.Prof. Yu's Interview Script (PDF)
